Recs

0

Impax to Present Rytary Trial Data Next Week

Watch stocks you care about

The single, easiest way to keep track of all the stocks that matter...

Your own personalized stock watchlist!

It's a 100% FREE Motley Fool service...

Click Here Now

Impax Pharmaceuticals (NASDAQ: IPXL  ) is to reveal details of its recent clinical trials for the Parkinson's disease treatment Rytary. The unveiling will occur on March 18 at the American Academy of Neurology conference in San Diego. The company has conducted phase III and open-label extension trials for the drug.

Impax describes Rytary as a "formulation of cabidopa-levodopa for the treatment of idiopathic Parkinson's disease."

The company has had its difficulties lately, with the Food and Drug Administration raising numerous points of concern about its Hayward, California facilities in the regulator's findings of the firm's pre-approval and good manufacturing practices.


Read/Post Comments (0) | Recommend This Article (0)

Compare Brokers

Fool Disclosure

Sponsored Links

Leaked: Apple's Next Smart Device
(Warning, it may shock you)
The secret is out... experts are predicting 458 million of these types of devices will be sold per year. 1 hyper-growth company stands to rake in maximum profit - and it's NOT Apple. Show me Apple's new smart gizmo!

DocumentId: 2316485, ~/Articles/ArticleHandler.aspx, 8/25/2016 12:56:33 AM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...

Today's Market

updated 3 hours ago Sponsored by:
DOW 18,481.48 -65.82 -0.35%
S&P 500 2,175.44 -11.46 -0.52%
NASD 5,217.70 -42.38 -0.81%

Create My Watchlist

Go to My Watchlist

You don't seem to be following any stocks yet!

Better investing starts with a watchlist. Now you can create a personalized watchlist and get immediate access to the personalized information you need to make successful investing decisions.

Data delayed up to 5 minutes

Related Tickers

8/24/2016 4:00 PM
IPXL $23.79 Down -0.08 -0.34%
Impax Laboratories CAPS Rating: ****

Advertisement